Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

$25.44
-1.09 (-4.11%)
NASDAQ Global Select
USD, US
Drug Manufacturers - Specialty & Generic

PCRX Price Chart

Basic
Market Cap$1.17B
Price$25.44
52 Week Range11.16-31.67
Beta0.80
Margins
Gross Profit Margin71.60%
Operating Profit Margin-9.81%
Net Profit Margin-14.20%
Valuation (TTM)
P/E Ratio-10.61
Price to Sales Ratio1.51
Price to Book Ratio1.36
PEG Ratio1.10

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Full-Time Employees

711

IPO Date

2011-02-03T00:00:00.000Z

Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Phone

813 553 6680

Address

5401 West Kennedy Boulevard, Tampa, FL, 33609, US

CIK

0001396814